An interventional cardiologist in Columbia, S.C., used a new mechanical thrombectomy (blood clot removal) system from the company to extract a 1-inch long blood clot from a saphenous vein to coronary artery bypass graft.
The patient presented with a long blood clot in an aged saphenous vein bypass graft diagnosed during a cardiac catheterization procedure. Lee Butterfield. M.D., used the combination of a protective filter, the new ASPIRE RX-LP6 Mechanical Thrombectomy system, and a stent to remove blood clots and dilate the stenosis.
“Compromised bypass grafts may include long viscous blood clots and emboli making them particularly difficult to treat,” said Butterfield, a doctor with Palmetto Cardiology. “The ASPIRE RX-LP6 System allowed us to create continuous thrombectomy force and remove a long blood clot from the patient’s vein graft. Once the blood clot was removed, we could better define a culprit lesion and deploy a 3.5-mm diameter stent.”
The ASPIRE Systems allow clinicians to instantly start, stop, increase, decrease, pulse, or maintain thrombectomy force during the procedure. ASPIRE Mechanical Aspirators also aspirate up to 280ml, almost 10 times more than basic syringe systems, without multiple messy and time-consuming catheter connections, disconnections, and re-connections, the company noted.
“The ASPIRE RX-LP6 Mechanical Thrombectomy System is an extension to the ASPIRE platform,” said Control Medical Technology CEO Shawn Fojtik. “Thousands of ASPIREs have been sold and used in procedures from the ankle to the elbow. Adding [U.S. Food and Drug Administration] FDA-cleared coronary thrombectomy catheters allows clinicians to bring mechanical thrombectomy to the heart and improve patient care.”
The patented ASPIRE RX-LP6 Mechanical Thrombectomy System includes an ASPIRE Mechanical Aspirator (drive unit/pump) and a low-profile rapid-exchange (RX) thrombectomy catheter. ASPIRE Mechanical Aspirators also are available alone and may be connected to any thrombectomy catheter the clinician chooses to use. Control Medical also manufactures ASPIRE MAX Mechanical Thrombectomy Systems with larger over-the-wire (OTW) thrombectomy catheters for use in the peripheral vasculature.
Control Medical Technology designs, develops, and markets innovative thrombus (blood clot) management, biopsy, and aspiration devices. The company has offices in Park City, Utah, and Hallandale Beach, Fla.